Cartesian Therapeutics, Inc. Property, Plant and Equipment, Gross
Cartesian Therapeutics, Inc. (RNAC) had Property, Plant and Equipment, Gross of $17.44 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $17.44M.
- 2026-03-31: Property, Plant and Equipment, Gross $16.98M.
- 2025-12-31: Property, Plant and Equipment, Gross $16.92M.
- 2025-09-30: Property, Plant and Equipment, Gross $16.52M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $17.44M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $16.98M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $16.92M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $16.52M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $15.80M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $13.10M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $12.27M 10-K · filed 2026-03-09 |
| 2024-09-30 | $16.54M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $12.70M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $8.23M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $7.84M 10-K · filed 2025-03-13 |
| 2023-09-30 | $8.16M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.17M 10-Q · filed 2023-08-17 |
| 2023-03-31 | $8.16M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $8.00M 10-K · filed 2024-03-07 |
| 2022-09-30 | $7.92M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $7.67M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $7.35M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.94M 10-K · filed 2023-03-02 |
| 2021-09-30 | $6.46M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $6.29M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.68M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $5.65M 10-K · filed 2022-03-10 |
| 2020-09-30 | $5.53M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.37M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.56M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $6.00M 10-K · filed 2021-03-12 |
| 2019-09-30 | $6.04M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $6.04M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $6.06M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $6.68M 10-K · filed 2020-03-12 |
| 2018-09-30 | $6.51M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $6.54M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $6.59M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $6.25M 10-K · filed 2019-03-15 |
| 2017-09-30 | $6.13M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $6.28M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $6.04M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $5.79M 10-K · filed 2018-03-15 |
| 2016-09-30 | $5.57M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $5.27M 10-Q · filed 2016-08-09 |
| 2015-12-31 | $4.96M 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |